14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.64 $2.30 Tuesday, 23rd Apr 2024 CTMX stock ended at $1.68. This is 0.599% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 5.49% from a day low at $1.64 to a day high of $1.73.
90 days $1.38 $2.86
52 weeks $1.04 $2.86

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
Sep 21, 2021 $5.21 $5.48 $5.16 $5.46 662 284
Sep 20, 2021 $5.10 $5.27 $5.06 $5.19 551 346
Sep 17, 2021 $5.10 $5.36 $5.00 $5.23 2 057 837
Sep 16, 2021 $4.99 $5.11 $4.81 $5.06 773 126
Sep 15, 2021 $5.00 $5.04 $4.87 $4.97 484 899
Sep 14, 2021 $5.28 $5.28 $4.98 $5.00 595 247
Sep 13, 2021 $5.13 $5.36 $5.03 $5.28 909 466
Sep 10, 2021 $5.22 $5.22 $5.04 $5.12 466 506
Sep 09, 2021 $5.10 $5.28 $5.07 $5.17 520 191
Sep 08, 2021 $5.17 $5.20 $5.03 $5.10 495 383
Sep 07, 2021 $5.16 $5.27 $5.06 $5.15 473 578
Sep 03, 2021 $5.22 $5.22 $5.05 $5.14 760 382
Sep 02, 2021 $5.21 $5.28 $5.09 $5.23 391 054
Sep 01, 2021 $5.16 $5.27 $5.11 $5.20 338 267
Aug 31, 2021 $5.10 $5.20 $5.06 $5.12 292 724
Aug 30, 2021 $5.20 $5.26 $5.03 $5.07 364 883
Aug 27, 2021 $4.99 $5.25 $4.98 $5.19 619 767
Aug 26, 2021 $4.99 $5.14 $4.99 $5.05 586 462
Aug 25, 2021 $4.94 $5.14 $4.90 $5.03 798 385
Aug 24, 2021 $4.88 $5.01 $4.76 $4.98 880 366
Aug 23, 2021 $4.75 $4.90 $4.70 $4.88 807 066
Aug 20, 2021 $4.38 $4.66 $4.28 $4.66 623 345
Aug 19, 2021 $4.53 $4.58 $4.30 $4.32 912 491
Aug 18, 2021 $4.86 $4.88 $4.59 $4.60 531 456
Aug 17, 2021 $4.74 $4.92 $4.73 $4.89 595 748
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT